Search

Dr. Eid will test the hypothesis that the Trio gene is a central regulator of the development and maturation of cortical interneurons (INs) and that its loss underlies some genetic forms of epileptic encephalopathies (EE) by disrupting cortical network development and function. Project Overview Dr....

“Increase your caloric intake.” This is the number one recommendation that a clinician will make to a person recently diagnosed with Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease affecting nerve cells in the brain and spinal cord, causing loss of muscle control. A high calorie...

Dr. Honglin Luo (left) and Dr. Neil Cashman. Discovery Grant empowers Canadian team to examine the cGAS-STING pathway across a range of ALS models “The Discovery Grant is very crucial for us,” says Dr. Luo, “since it allows us to quickly look at the outcome.” Dr. Cashman also emphasizes speed as a...

Discovery Grant will fuel an interdisciplinary mindfulness study for people living with ALS and their caregivers “Research suggests that being more mindful may allow people a greater sense of perceived control. This is doubly relevant because an ALS diagnosis can bring about elements of fear and...

The program will leverage AbCellera’s high-throughput, single-cell screening platform to allow rapid identification of functional antibodies against complex membrane proteins. MONTREAL, January 12th, 2018– CQDM and Brain Canada are proud to announce the non-dilutive funding of $1 M to AbCellera and...

CQDM and Brain Canada are proud to announce the funding of three collaborative research projects, for a total of $7.4 million which includes financial support from various industry partners, aimed at addressing unmet needs in the treatment of brain disorders. These projects are made possible by a...

Montreal, May 2nd, 2019 – CQDM is pleased to announce that Professor Philippe Gros from McGill University has been awarded $1.5 million as part of the SynergiQC program to pursue the development and validation of new inhibitors of ubiquitin-specific protein protease (USP-15) and its partner TRIM25,...

Learning in Machines and Brains Senior Fellow, Joëlle Pineau, presents at the December 2015 meeting of CIFAR’s program Learning in Machines and Brains Learning in Machines and Brains is one of the 14 global research programs at CIFAR (Canadian Institute For Advanced Research). The CIFAR research...

Bright flashes of green and yellow mark the spots where Farmington virus is killing susceptible target cells (red). David Stojdl and his team are trying a different way to treat brain tumours. Their lab has custom-built an oncolytic virus biotherapy specifically for the treatment of the devastating...

The proposed research in this application will significantly broaden our understanding of the molecular basis for how stress leads to anxiety and depression. Project Overview The proposed research in this application will significantly broaden our understanding of the molecular basis for how stress...